Log In
Print
BCIQ
Print
Print this Print this
 

levodopa/carbidopa/entacapone (ODM-101)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionOptimized formulation of levodopa plus dopa decarboxylase (DDC) inhibitor and catechol-O-methyl-transferase (COMT) inhibitor
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationParkinson's disease (PD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today